287 related articles for article (PubMed ID: 6366107)
1. Defective production of monocyte-activating cytokines in lepromatous leprosy.
Horwitz MA; Levis WR; Cohn ZA
J Exp Med; 1984 Mar; 159(3):666-78. PubMed ID: 6366107
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity in Legionnaires' disease.
Horwitz MA
J Clin Invest; 1983 Jun; 71(6):1686-97. PubMed ID: 6345589
[TBL] [Abstract][Full Text] [Related]
3. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
4. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
6. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
7. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
[TBL] [Abstract][Full Text] [Related]
8. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
9. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
10. Activation and cytokine profile of monocyte derived dendritic cells in leprosy: in vitro stimulation by sonicated Mycobacterium leprae induces decreased level of IL-12p70 in lepromatous leprosy.
Braga AF; Moretto DF; Gigliotti P; Peruchi M; Vilani-Moreno FR; Campanelli AP; Latini AC; Iyer A; Das PK; Souza VN
Mem Inst Oswaldo Cruz; 2015 Aug; 110(5):655-61. PubMed ID: 26222022
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 beta production by monocytes from leprosy patients.
Choi IH; Shin JS; Park SK; Cho SN; Kim JD; Kim SJ
Yonsei Med J; 1990 Dec; 31(4):301-7. PubMed ID: 2077754
[TBL] [Abstract][Full Text] [Related]
12. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.
Horwitz MA; Silverstein SC
J Exp Med; 1981 Nov; 154(5):1618-35. PubMed ID: 7299350
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of chemiluminescence, procoagulant activity and antigen presentation by monocytes from lepromatous leprosy patients with or without reactional episodes.
Santos DO; Suffys PN; Moreira AL; Bonifacio K; Salgado JL; Esquenazi D; Bertho AL; Sarno EN
Lepr Rev; 1994 Jun; 65(2):88-99. PubMed ID: 7968194
[TBL] [Abstract][Full Text] [Related]
14. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
[TBL] [Abstract][Full Text] [Related]
15. In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients.
Stoner GL; Touw J; Belehu A; Naafs B
Lancet; 1978 Sep; 2(8089):543-7. PubMed ID: 79915
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
Nash TW; Libby DM; Horwitz MA
J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
[TBL] [Abstract][Full Text] [Related]
17. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
[TBL] [Abstract][Full Text] [Related]
19. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
